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The Fanconi anemia (FA) pathway maintains genome stability through co-ordination of DNA repair
of interstrand crosslinks (ICLs). Disruption of the FA pathway yields hypersensitivity to interstrand
crosslinking agents, bone marrow failure and cancer predisposition. Early steps in DNA damage
dependent activation of the pathway are governed by monoubiquitylation of FANCD2 and FANCI
by the intrinsic FA E3 ubiquitin ligase, FANCL. Downstream FA pathway components and associated
factors such as FAN1 and SLX4 exhibit ubiquitin-binding motifs that are important for their DNA
repair function, underscoring the importance of ubiquitylation in FA pathway mediated repair.
Importantly, ubiquitylation provides the foundations for cross-talk between repair pathways, which
in concert with the FA pathway, resolve interstrand crosslink damage and maintain genomic
stability.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
First described as a signal for protein degradation [1] modiﬁca-
tion by ubiquitin functions extensively as a regulatory signal to
control diverse biological pathways. As seen by the reviews in this
issue, DNA damage is a fertile ground for identiﬁcation of ubiquitin
function. Here we concentrate on Fanconi anemia (FA), a rare but
very instructive disease for ubiquitin signaling. FA patients show
defects in DNA interstrand crosslink repair and have biallelic muta-
tions in one of fourteen genes that code among others, for a ubiq-
uitin ligase (FANCL), proteins modiﬁed by monoubiquitylation
(FANCD2 and FANCI), and a protein with ubiquitin-binding do-
mains (FANCP/SLX4). The functional implications of ubiquitylation
and de-ubiquitylation within the FA pathway and the regulation of
interstrand crosslink repair will be the focus of this review.
2. The Fanconi anemia pathway
Fanconi anemia (FA) is a pathologically diverse, recessively
inherited disease that typically culminates in bone marrow failure
in affected individuals. Patients also display profound genome
instability that correlates with cancer predisposition and may have
developmental defects [2]. On a molecular level, the FA pathway
represents a facet of the cellular DNA repair strategy employedchemical Societies. Published by E
A. Smogorzewska).to resolve DNA damage, particularly interstrand crosslinks (ICLs),
which covalently link the Watson and Crick strands of the DNA.
ICLs particularly affect processes that inherently require DNA
unwinding and strand separation such as DNA replication and
transcription [3] (Fig. 1A). Consequently, ICLs are particularly del-
eterious if unresolved. Besides being activated by exogenous dam-
age inﬂicted by DNA crosslinking agents such as diepoxybutane
(DEB), mitomycin C (MMC) or cisplatin, FA proteins are activated
during normal S phase suggesting that they might participate in re-
pair of replication errors [4,5].
Identiﬁcation of mutated genes in FA patients has paved the
way for the identiﬁcation of a diverse set of proteins necessary
for crosslink repair. A ‘genuine FANC protein’ must be rooted in
the human disorder. This is usually a consequence of mutation
leading to loss of gene function. Currently biallelic mutations in
any one of the 14 genes is responsible for FA with the 15th gene
(RAD51C) being mutated in an FA-like syndrome [6] (Fig. 1). The
known patients with RAD51C mutations have not yet presented
signs of bone marrow failure and as such RAD51C has not yet been
assigned an ofﬁcial FANC name. A FANCO designation has been set
aside if more evidence is gathered to ﬁrmly establish RAD51C as an
FA gene. Eight proteins (FANCA, FANCB, FANCC, FANCE, FANCF,
FANCG, FANCL, FANCM) form a complex commonly referred to as
the core complex which monoubiquitylates both components of
the ID complex, FANCD2 and FANCI [4,7–9] (Fig. 1B). Although
FANCM has been ﬁrst reported as an essential component of the
core complex [10], it is now clear that FANCM is important for
resistance to interstrand crosslinks but not at the step oflsevier B.V. All rights reserved.
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Fig. 1. Ubiquitylation in response to interstrand crosslinks, highlighting Fanconi anemia proteins and the associated factors necessary for repair. Particular attention is drawn
to some of the unknown factors in interstrand crosslink repair. (A) Interstrand crosslinks prevent separation of the DNA helix. During replication this can lead to replication
fork collapse when forks encounter lesions from one or both directions. For a full model of DNA transactions, see [63,64]. This leads to RPA-ssDNA binding and activation of
the ATR and the downstream DNA damage response. (B) Activation of the ID complex. ATR phosphorylates many FA proteins including FANCI. FANCI phosphorylation acts as a
molecular switch in the FA pathway. The FA core complex is recruited to chromatin at sites of damage where it functions as an E3 ubiquitin ligase to monoubiquitylate the ID
complex at the damage site. It is currently unknown if there are other substrates for ubiquitylation by the FA core complex. (C) UBZ domain containing effectors. Downstream
effectors FAN1, SLX4, and SNM1A harbor ubiquitin-binding motifs that are thought to target them to the site of damage through ubiquitin mediated interactions. FAN1 binds
the monoubiquitylated FANCD2. SLX4 displays binding afﬁnity for ubiquitin chains though the docking sites for SLX4 are not currently known. SLX4 could potentially interact
with ubiquitylated FANCD2 or PCNA. Interestingly all three proteins harbor nuclease activity or are associated with nucleases. Thus, control of ubiquitylation events regulates
the localization of nucleases at the site of damage. One of the remaining questions is why there are so many nucleases at the repair sites. (D) Translesion synthesis step.
Chromatin bound PCNA is monoubiquitylated by RAD18 in response to interstrand crosslinking damage and coordinates translesion synthesis steps during interstrand
crosslink repair. Additional, non-PCNA and non-RAD18-dependent events are likely to allow translesion synthesis to occur. Homologous recombination (HR) concludes the
repair process. FA proteins BRCA2, PALB2, and the Fanconi anemia-like syndrome protein RAD51C are involved in this step. FANCJ is also important for HR but in the context
of FA, it clearly has other functions, which are not yet fully explored.
2854 E. Garner, A. Smogorzewska / FEBS Letters 585 (2011) 2853–2860monoubiquitylation of the ID complex [11]. Furthermore, unlike
the other components of the core complex, FANCM has FA pathway
independent function including ATR-mediated checkpoint signal-
ing [12]. Monoubiquitylated ID complex interacts with FAN1 (Fan-
coni anemia Associated Nuclease 1), which in vitro has both endo-
and exo-nuclease activity [13–16]. There are no known FA patientswith mutations in FAN1. The downstream proteins in the pathway
include FANCD1/BRCA2 and the BRCA2 interacting partner,
FANCN/PALB2 [17–19], both of which are essential components
of homologous recombination repair, and a helicase FANCJ /
BRIP1/BACH1 [20–23]. FANCJ interacts with BRCA1 but this inter-
action is apparently dispensable in the context of FA pathway
E. Garner, A. Smogorzewska / FEBS Letters 585 (2011) 2853–2860 2855[24]. Depletion of BRCA1 results in exquisite sensitivity of cells to
crosslink damage but no individuals with biallelic BRCA1 muta-
tions have been found to date. The newest addition to the Fanconi
anemia protein family is FANCP/SLX4 [25–27]. SLX4 acts as a
scaffold that interacts with multiple proteins including nucleases
XPF, MUS81 and SLX1 [28–30]. XPF and MUS81 have been previ-
ously implicated in crosslink repair [31,32] and the SLX4-SLX1
interaction is responsible for Holliday junction resolution activity
in vitro. It is unclear at this point which activity of SLX4 is essential
for crosslink repair. Besides the genuine FANC proteins discussed
above, numerous proteins have been demonstrated to be associ-
ated with FA pathway components and as such need to be studied
in parallel. Technological advances including RNAi continue to
facilitate the identiﬁcation of proteins whose absence yields a
genome instability phenotype analogous to that of FA and the next
generation sequencing approaches should soon identify the
remaining FANC genes in FA patients with thus far unidentiﬁed
genetic mutations.
Besides the major pathway of replication-dependent ICL repair,
vertebrate cells also have a replication-independent repair path-
way. This minor repair pathway is active during G0/G1 stages and
is independent of replication and homologous recombination but
dependent upon the nucleotide excision repair components XPC
and XPA [33–37]. Many of the components of the FA pathway
including the core complex, FANCI and FANCD2 seem to be required
for this repair [38]. The key to understanding crosslink repair will
be careful molecular and biochemical dissection of function of the
proteins involved in repair including crystallographic studies of
the pathway’s components. It is clear that characterization of the
ubiquitin-driven events and nuclease regulation in the pathway
will be key to understanding the Fanconi anemia pathway.3. The E3 ubiquitin ligase activity of FANCL and the FA core
complex
Ubiquitylation of FANCD2 and FANCI is absent in cells with
mutations in the core complex components (except for FANCM).
Prior to the identiﬁcation of FANCL, the core complex was not
shown to harbor proteins with any recognizable domains. At that
time, other known ubiquitin ligases such as BRCA1 were under
scrutiny in efforts to identify the components required for this
central step in FA pathway regulation [7,39]. It was not until the
identiﬁcation of FANCL that it was possible to attribute monoubiq-
uitylation of FANCD2 as an intra-FA pathway step in the response
to ICLs [40].
FANCL is considered a key part of the FA core complex and rep-
resents the E3 ligase necessary for ubiquitin conjugation to lysine
561 of human FANCD2 and lysine 523 of FANCI. Structurally FANCL
has three distinct domains; an ELF, DRWD and RING domain [41].
Functionally, the DRWD domain coordinates substrate binding
while the RING domain is required for E2 protein interactions.
Yeast two hybrid experiments using full-length FANCL have iden-
tiﬁed two E2 proteins capable of interacting with FANCL, UBE2T
and UBE2W [42]. The C-terminal RING domain is both necessary
and sufﬁcient for FANCL binding of UBE2T [43]. The importance
of the RING domain is reﬂected in the evolutionary conservation
of this domain in FANCL homologs [41]. UBE2T is considered to
be the most functionally important E2 enzyme required for
FANCL-mediated ubiquitylation of FANCD2 in vivo and is required
for cellular resistance to ICLs [43]. In vitro data differ from in vivo-
derived data as to the minimal requirements for FANCD2 monoub-
iquitylation, since E1, UBE2T, and FANCL are shown to be sufﬁcient
for FANCD2 monoubiquitylation in an in vitro context [42]. How-
ever, this reaction was quite inefﬁcient and ubiquitylation
occurred only on FANCD2, even when FANCI was also present inthe reaction. Interestingly, presence of FANCI conferred speciﬁcity
to the reaction so that K561 of FANCD2 was now correctly
monoubiquitylated. This suggests that FANCI might direct the cor-
rect lysine residue to the core complex or perhaps mask alternative
surface lysines. Reconstitution of the whole core complex might be
necessary for robust in vitro ubiquitylation. In addition, since phos-
phorylation plays an important role in activating the pathway,
using pre-activated FANCI (see below) might be required.
FANCD2 and FANCI are the only known substrates of the core
complex. There remains a possibility that there will be other sub-
strates for this complicated E3 ligase (Fig. 1B and D). A hint of that
might be seen in the result showing that monoubiquitylated
FANCD2 on the chromatin is not sufﬁcient for crosslink resistance
in DT40 cells that lack the FA core complex [44]. Since FANCI
monoubiquitylation in DT40 cells is almost non-contributory (see
next section), it is likely that there will be other substrates of
FANCL.4. Regulation of ID complex monoubiquitylation
Monoubiquitylated ID complex is at the heart of the Fanconi
anemia pathway. The monoubiquitylation of FANCD2 at lysine
561 is essential for the downstream function of the FA pathway
in repair. Cells expressing K561R FANCD2 (which cannot be
monoubiquitylated) as the only FANCD2 allele are as sensitive to
crosslinking agents as null cells [7]. The contribution of monoubiq-
uitylated FANCI to crosslink resistance seems to be less important
than that of monoubiquitylated FANCD2 in human cells [4], and al-
most non-contributing in DT40 cells [45]. Monoubiquitylation of
FANCD2 occurs following the localization of the core complex to
sites of damage (Fig. 1B). Core complex localization requires the
combined activity of FANCM and its interacting factor FAAP24 that
facilitates the recruitment of the core complex to regions of dam-
age [46,47]. The recruitment of FANCM to sites of damage is en-
hanced further by the association of FANCM with additional
FAAP proteins, MHF1 and MHF2 [48]. MHF1 and MHF2 contain
putative histone fold domains and form a dimeric complex with
DNA binding afﬁnity. MHF1 and 2 are found in complex with
FANCM and FAAP24 in mammalian cells and MHF1 is critical for
the integrity of the complex. The MHF dimer complex augments
the association of FANCM with chromatin and enhances FANCM
dependent processing of branched DNA. Destabilization of the
MHF1/2 dimer complex with FANCM by silencing of MHF1 expres-
sion leads to a decreased efﬁciency of FANCD2 monoubiquitylation
in response to DNA damage and increased genome instability.
It is unclear how the ID complex localizes to chromatin before it
is monoubiquitylated. It does posses intrinsic DNA-binding activity
[49–51] with preference for branched structures, so it is possible
that it gets to the sites of damage on its own via DNA binding. Once
monoubiquitylated, it clearly resides at chromatin where it can be
found in damage-induced foci [4,7]. It has been previously pro-
posed that a chromatin receptor for the monoubiquitylated ID
complex might be present at the chromatin [44,52,53], although
such a receptor has not yet been identiﬁed. In the light of FAN1
binding to the chromatin bound monoubiquitylated ID complex
(see below), existence of such a receptor is less likely, although
not impossible. If such a receptor does exist, understanding of
the re-modeling of the ID complex architecture from interacting
with a receptor via monoubiquitin to interacting with FAN1 and
other effector proteins at chromatin will be very important.
Fanconi anemia proteins are regulated by DNA damage signal-
ing involving ATM and ATR kinases. ATM is activated in response
to double-strand breaks and in a manner that involves DNA resec-
tion while ATR signals replicative stress and is activated by binding
of ATR/ATRIP to the RPA coated ssDNA [54,55] (Fig. 1A). Multiple
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FANCA, FANCG, FANCM, FANCD1 and both constituents of the ID
complex [4,5,10,45,56–62]. The importance of many of the phos-
phorylation events is not entirely clear but some of them are
important for crosslink resistance. In particular, phosphorylation
of FANCI on SQ/TQ sites close to the monoubiquitylation site of
FANCI is necessary for the monoubiquitylation and localization of
both FANCI and FANCD2 to damage-induced foci [45]. FANCI carry-
ing phosphomimic mutations of these sites showed constitutive
activation of the pathway even in the absence of damage. Based
on these ﬁndings, it has been proposed that FANCI phosphorylation
functions as a molecular switch to turn on the FA pathway.
Although it is unclear how this switch my work, one possibility
is that phosphorylation of FANCI drives an interaction of the ID
complex with a protein that interacts with the core complex or
with a protein in the core complex itself. It will be important to
understand how phosphorylation of FANCI triggers monoubiquity-
lation of FANCD2.
5. Ubiquitin mediated interaction of the ID complex and FAN1
The chromatin bound monoubiquitylated ID complex facilitates
subsequent steps of ICL repair in ways that are still being eluci-
dated. The ID complex and monoubiquitylation of FANCD2 is re-
quired for ICL unhooking and translesion DNA synthesis to
facilitate bypass of the lesion [63,64]. It is likely that monoubiqui-
tylation of the ID complex forms a platform for at least some of
these events and that the protein components involved in making
the incisions and translesion synthesis may harbor ubiquitin-bind-
ing motifs themselves (Fig. 1C). The newly identiﬁed nuclease re-
quired for ICL repair, FAN1, is one such protein. FAN1 has a UBZ
domain at its N terminus. UBZ (ubiquitin binding zinc ﬁnger) do-
main is one of many ubiquitin recognition motifs (reviewed in
[65]). Mutation of the UBZ domain precluded FAN1 from localizing
to damage made by laser irradiation or by crosslinking damage
[13–16]. The ID complex was also required for foci formation by
FAN1. Moreover, cells with endogenous FANCD2 replaced with
the K561R FANCD2 mutant lost FAN1 localization. Since FANCD2
and FAN1 were able to interact in immunoprecipitation experi-
ments, monoubiquitylated FANCD2 is considered a platform for
FAN1 binding through the UBZ domain. Other regions of FAN1 pro-
tein might also be required for interaction with FANCD2 analogous
to REV1 interacting not only with the monoubiquitin on PCNA but
also with PCNA itself through the BRCT motifs [66]. Since FAN1 dis-
plays both endonuclease and exonuclease activity this ubiquitin-
mediated recruitment focuses the nuclease activity of FAN1 to
the site of the ICL. Thus far, in vitro experiments have been per-
formed on non-crosslinked substrates so it is unclear at which step
of repair FAN1 acts. It may work in concert with the MUS81-EME1
and XPF-ERCC1 nuclease that have been implicated in crosslink
unhooking [31,32]. It might also act at the later stages of excision
of the unhooked crosslink or even later during preparation for
homologous recombination events. The concept of ubiquitin-
mediated recruitment via the ID complex will undoubtedly be an
important aspect of understanding the downstream processes of
FA pathway-mediated DNA repair. It will be interesting to uncover
how the ID complex co-ordinates the downstream effectors of the
pathway, some of which may yet to be identiﬁed.6. Deubiquitylation and FA pathway regulation
Ubiquitylation of the ID complex is an activating event neces-
sary for the repair of ICLs. Equally important is the event of turning
that signal off once the repair is completed. Failure to de-ubiquity-
late the ID complex results, somewhat counter intuitively, insensitivity to crosslinking agents [67,68]. This implies that the cy-
cling of the ID complex between ubiquitylated and non-ubiquity-
lated forms is essential for the activity of the pathway. USP1 is
the deubiquitylating enzyme that interacts with FANCD2 in chro-
matin and removes its monoubiquitin [69] (Fig. 2). USP1 is regu-
lated on many levels. USP1 levels are tightly regulated at a
transcriptional level to peak during S-phase, presumably when
its activity is most required. It is also regulated by polyubiquityla-
tion and proteasome-dependent degradation at the end of S phase
once it is no longer needed. USP1 levels during S phase however
are fairly constant [69]. This implies that there will be as of yet
unidentiﬁed regulatory steps in the pathway, possibly at the chro-
matin level, which will allow deubiquitylation of FANCD2 and
resetting of the pathway. Interestingly, upon damage USP1
transcription is shut off with a subsequent rapid decline of USP1
protein [70]. It is not known what happens to the chromatin-
associated USP1 pool after DNA damage and it is this fraction of
USP1 that is of particular interest. It is unlikely that it disappears;
rather its activity is probably regulated in some way to allow for
de-ubiquitylation of the ID complex only after the damage is re-
paired. USP1 activity is greatly enhanced by its partner, a WD40
domain containing protein, USP1 Associated Factor 1 (UAF1) [70].
Future work should concentrate on regulation of USP1 since our
appreciation of the mechanisms of deactivation, lags behind our
understanding of the activation of the Fanconi anemia pathway.
Interestingly, USP1 is also a de-ubiquitylating enzyme for PCNA
(Fig. 2), suggesting that regulation of de-ubiquitylation of PCNA
and the ID complex might be co-regulated. Clearly there will also
be separate regulatory networks, for example ELG1 interacts with
USP1-UAF1 and affects PCNA deubiquitylation, but not FANCD2
ubiquitylation status [71].7. The Ubiquitin binding motifs of FANCP/SLX4
FANCP/SLX4 represents the newest member of the FA pathway
to date and constitutes the 14th Fanconi anemia complementation
group FA-P [26,27]. The SLX4 protein is a large scaffold with multi-
ple recognizable domains. At the N terminus, it has two UBZ do-
mains followed by an MLR (MUS312/MEI9 interaction like
region), BTB domain, SAP domain, and ﬁnally a helix-turn-helix
motif at the C terminus [28–30]. Human SLX4 interacts with multi-
ple proteins including XPF-ERCC1, MUS81-EME1, SLX1, MSH2,
MSH3, TRF2, RAP1, and PLK1 among others. It appears that most
if not all of the cellular pool of MUS81 and SLX1 interact with
SLX4 while only a small portion of the cellular XPF pool interacts
with SLX4 [30]. In vitro SLX4 is able to enhance the activity of
the associated nucleases. Cells derived from FA-P patients display
normal monoubiquitylation of FANCD2 following DNA damage
but genomic instability and sensitivity to inter-strand crosslinking
agents characteristic of an FA phenotype. The early steps of ICL re-
pair that requires the core components of the FA pathway are unaf-
fected by a loss of SLX4 suggesting that it is a downstream effector
of the pathway [26,27]. Obvious candidates for the essential com-
ponents of SLX4 in the setting of FA are XPF and MUS81 but the ex-
act role of SLX4 in FA pathway still needs to be determined. Patient
mutations suggest an important role for the UBZ domains. Two of
the four families with SLX4 mutations have a very interesting in-
frame internal deletion of amino acids 317–387, corresponding
to half of the ﬁrst UBZ domain and the whole second part of UBZ
domain. Although the level of expression of this allele was lower
than wild type, it was able to interact with XPF and MUS81.
The UBZ domains of SLX4 interact efﬁciently with K63-linked
ubiquitin chains in vitro in a manner that requires intact UBZ
domains [26]. Mutation of the two cysteines in both of the UBZ
domains resulted in abrogation of ubiquitin chain binding. These
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via ubiquitin mediated interactions. The substrates of such interac-
tions are unknown at this time (Fig. 1C). It is still possible that SLX4
interacts with monoubiquitylated ID complex as suggested for the
chicken FANCP in DT40 cells [72]. However, the presence of tan-
dem UBZ domains would be consistent with SLX4 binding to a tar-
get that is endowed with ubiquitin chains. Identity of ubiquitylated
substrates is a hot subject and identiﬁcation of these in the context
of the FA pathway will be truly exciting. It is appealing to think
that different nucleases will arrive at the sites of a crosslink via dif-
ferent, albeit ubiquitin-dependent interactions. FAN1 would arrive
via monoubiquitylated ID complex, SLX4/XPF/MUS81 complex, via
a different, unknown interactor. This would give an opportunity to
regulate these nucleases separately and make sure that the inci-
sions are made only at the correct sites and at the right time.
8. Translesion polymerases in the ICL repair
Translesion synthesis (TLS) polymerases are specialized en-
zymes that are able to insert a nucleotide across a damaged site
in DNA. Multiple translesion polymerases have been implicated
in the FA pathway. Knockout of REV1, and components of POLf
(REV3, REV7) in chicken DT40 cells leads to exquisite sensitivity
to crosslinking agents [73–77]. Moreover REV1 and REV3 are epi-
static with FANCC for crosslink sensitivity suggesting that they
are in the same pathway [73,75]. The current model for ICL repair
based on the repair of a crosslinked plasmid in Xenopus egg extract
proposes that translesion polymerases are essential for the bypass
of the crosslink that was freed, commonly referred to as ‘‘un-
hooked’’, by endonucleolytic incisions [63,64]. It has been pro-
posed that REV1 inserts one nucleotide against the unhooked
crosslink, which is further extended by the REV3 catalytic subunit
of POLf [63,64]. Depletion of FANCD2 affected the translesion step
as well as the ‘‘unhooking’’ step. It is not yet known whether both
of these events are direct consequences of FANCD2 depletion. It is
possible that both of these activities are co-regulated by the ID
complex or that the ID complex regulates only one of them and
that the second depends upon the initiation (or even completion)
of the ﬁrst. Interestingly, REV1 focus formation due to ICLs is
dependent on the functional FA core complex but does not seem
to involve FANCD2 or RAD18-dependent PCNA monoubiquityla-
tion [78] (Fig. 1D). How the translesion polymerases get to theICL is an exciting topic. Many others polymerases might also be in-
volved in ICL repair including POLg, POLj, POLi, POLh, and POLm.
The involvement of these polymerase was recently extensively re-
viewed in [79]. Of particular interest to the FA pathway is POLm
(POLN), which is an A type DNA polymerase. Depletion of POLN
in human cells results in DNA crosslink sensitivity with defects
in homologous recombination [80]. POLN was found to interact
with monoubiquitylated FANCD2 on chromatin after mitomycin
C treatment, although it is unclear if monoubiquitylation of
FANCD2 is required for the interaction, Furthermore, the POLN
dependent requirements for this interaction are not yet known.
9. RAD18 and FA pathway activation
Although RAD18 does not seem to be involved in REV1 localiza-
tion to ICLs, lack of RAD18 has been reported by several laborato-
ries to be involved in activation of the FA pathway since depletion
or lack of RAD18 led to slower kinetics of FANCD2 and FANCI
monoubiquitylation [81–84]. The mechanism of how RAD18 might
affect ID complex monoubiquitylation is not clear at this time since
the published data from different groups do not agree with each
other. RAD18 is an E3 ligase and together with RAD6 it has been
shown to catalyze monoubiquitylation of PCNA on lysine 164
and this modiﬁcation promotes error-prone translesion bypass
[85,86]. According to two papers [82,83], PCNA ubiquitination on
lysine 164 is required for activation of the FA pathway upon cis-
platin or benzo[a]pyrenedihydrodiol epoxide (BPDE) damage and
that ubiquitylated PCNA recruits the core complex which in turn
ubiquitylates the ID complex. Findings of Williams et al. [81] con-
tradict those conclusions. They show that RAD18 co-immunopre-
cipitates with FANCD2 and that the RING domain of RAD18 is
necessary for this interaction. However, they show that FANCD2
ubiquitylation is normal after mitomycin C treatment of cells con-
taining an ubiquitylation-resistant form of PCNA, and that the
chromatin loading of FA core complex proteins appears normal
in RAD18-knockout cells. The authors suggest that RAD18 could
be responsible for modifying the core complex itself or other
unidentiﬁed DNA repair proteins upstream of the ID complex.
These discrepancies need to be addressed by the labs that reported
these ﬁndings. There were some obvious differences in cell lines
and in damaging agents used between all the reports, including
the use of BPDE and cisplatin in reports describing PCNA
2858 E. Garner, A. Smogorzewska / FEBS Letters 585 (2011) 2853–2860monoubiquitylation-dependent mechanism, and mitomycin C in
the report that did not. Regardless of the mechanism, RAD18 is cer-
tainly a factor that regulates the FA pathway.10. Ubiquitin binding motif of SNM1A
Saccharomyces cerevisiae SNM1 (sensitivity to nitrogen mus-
tard), also known as PSO2 (sensitivity to psoralen), has been iden-
tiﬁed in screens for selective sensitivity to ICLs [87,88]. The 50 to 30
exonuclease activity of Pso2p is thought to be important for pro-
cessing of incisions made by nucleotide excision repair in yeast.
In vertebrates, there are three orthologs of SNM1; SNM1A,
SNM1B/Apollo, and SNM1C/Artemis (for review see [89]) SNM1A
and SNM1B both seem to participate in ICL repair, and the double
knockout in DT40 cells is more sensitive to cisplatin than either of
the single knockouts, suggesting that they function in separate
pathways or that they are redundant for cisplatin resistance [90].
SNM1A is also not epistatic in crosslink resistance with FANCC,
RAD18 or XRCC3 (homologous recombination pathway) in DT40
cells. SNMA1A, but not SNM1B was able to complement crosslink
sensitivity of the yeast Pso2 mutant [91] suggesting that SNM1 is
a functional ortholog of Pso2. Recent work led to the identiﬁcation
of a PIP box motif in vertebrate SNM1 required for binding to PCNA
irrespective of DNA damage [71]. A newly identiﬁed UBZ domain in
the N-terminus of SNM1A, which is conserved even in S. cerevisiae
Pso2, was required for damage induced foci formation by a GFP-
tagged SNM1 in human cells (Fig. 1C). SNM1A foci formation after
DNA damage was dependent on RAD18 [71] though the functional
consequences of these interactions are not yet clear. It remains to
be determined whether SNM1B functions in crosslink repair in hu-
man cells.11. Evolutionary conservation of proteins in the Fanconi
anemia pathway
The most conserved of the FA proteins are FANCM, SLX4 and
BRCA2, orthologs of which are present from yeast to human [28–
30,92–94]. Such an exquisite conservation; however, may reﬂect
functions of these proteins outside of ICL repair. Vertebrates, ﬂies,
frogs, worms, plants and even a slimemold D. discoideum, have rec-
ognizable orthologs of some of the components of the core com-
plex, importantly FANCL [41,95–98]. Conservation of the
components of the core complex, other than FANCL, ﬂuctuate
throughout evolution with some components lost or gained in dif-
ferent species (reviewed in [98]). All organisms that have FANCL
also have FANCD2 and FANCI, which have been shown to be
monoubiquitylated in some [64,95,97,98]. S. cerevisiae and Saccha-
romyces pombe have no core complex nor ID complex components.
However, S. pombe does have a FAN1 ortholog whose function is
unknown. S. pombe Fan1 has a well-conserved nuclease domain
and a SAP domain but no recognizable ubiquitin binding domain
[16]. SAP (SAF-A/B, Acinus and PIAS) domains have been postulated
to be modules involved in targeting proteins to chromatin [99]. As
such, it is possible that the SAP domain in the S. pombe FAN1 might
be involved in the localization of FAN1 to sites of damage.
Both S. cerevisiae and S. pombe have Slx4 orthologs. Indeed, Slx4
and Slx1 were ﬁrst identiﬁed in yeast in a screen for factors re-
quired for the viability of S. cerevisiae lacking RecQ helicase Sgs1
[100]. There are clear similarities between the yeast and human
orthologs of Slx4 in that they both interact with XPF-ERCC1 and
SLX1 orthologs [101]. SLX4 from yeast to human also contains
SAP domains and the C-terminal Helix-turn-helix domains. The
Slx4 orthologs in yeast do not have the UBZ domains, BTB domains
nor do they interact with MUS81. These differences suggest that
there has been an evolutionary expansion of SLX4 function, butalso adoption of MUS81 into the SLX4 complex, offering an oppor-
tunity for coordination of multiple nuclease activities through the
SLX4 protein.
12. Proteolysis and DNA damage signaling
Ubiquitylation clearly plays pan-cellular roles that are critical for
signaling and, as discussed here, crucial for FA pathway regulation
and DNA repair. Monoubiquitylation and polyubiquitin chains
may be of primary importance in signaling events, as platforms for
complex interactions. However, the importance of proteolytic deg-
radation in response to polyubiquitylation and proteasome target-
ing cannot be underestimated in terms of its importance for DNA
repair. Many of the regulatory factors discussed here may be tar-
geted for proteasomal degradation as is the case for the FA regula-
tory deubiquitylating enzyme USP1 (discussed above, Fig. 2) and
FANCM, which is degraded during M phase, releasing the core com-
plex from chromatin [102]. It has also been shown that proteasome
function is in fact required for monoubiquitylation and foci forma-
tion of FANCD2 [103]. The proteasome has also been linked to vari-
ous aspects of DSB repair and homologous recombination [104,105].
Understanding how the proteasome balances the accumulation of
repair factors with their degradation will involve a more thorough
understanding of polyubiquitylation targets. In turn, how the pro-
teasome is localized at sites of damage and its regulation is an
important aspect of DNA damage signaling and repair.
13. Perspectives
There is a lot to be learned about the role of ubiquitylation in
the Fanconi anemia pathway. Many of the remaining issues were
noted in their respective sections above. Here we highlight a few,
including the activation of ubiquitylation of the ID complex, role
of ubiquitin in regulation of nucleases, and a potential role of other,
ubiquitin-like modiﬁers in the FA pathway.
13.1. Turning on ubiquitylation
Phosphorylation of FANCI turns on the FA pathway in response
to damage. Understanding how this takes place is an important
concept in how ubiquitylation events occur in response to chal-
lenges such as DNA damage. Are ubiquitin ligase complexes consti-
tutively active such that the recruitment of substrates to the ligase
complex is the regulated step? Are ubiquitin ligase complexes
themselves activated by post-translational modiﬁcation? In the
case of damage-induced ubiquitylation of the ID complex it may
be that phosphorylation of both the core complex and the ID com-
plex regulate the ‘activation’ of ID complex ubiquitylation. In this
respect phospho-binding motifs may be the chromatin ‘receptors’
that localize core complex with substrate leading to ubiquitylation.
13.2. Targets of FANCL monoubiquitylation
Thus far only FANCD2 and FANCI have been identiﬁed as targets
of FANCL monoubiquitylation. It is compelling to think that there
may be alternative targets for FANCL monoubiquitylation. This
hypothesis is supported by the observation that the core complex
is not dispensable for crosslink repair even when FANCD2
monoubiquitylation has been satisﬁed [44]. The missing monoub-
iquitylated factor in that study could have been FANCI, however,
FANCI monoubiquitylation appears not to be very important in
the DT40 cells. In light of these ﬁndings, there still might be some
missing substrates of the core complex. Experimentally, ﬁnding
alternative targets of FANCL monoubiquitylation may not be sim-
ple. Such a modiﬁcation is not represented in abundance and
dissecting monoubiquitylated targets from polyubiquitylated
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of posttranslational modiﬁcation (like the phosphorylation switch
of FANCI for the ID complex ubiquitylation) may complicate efforts
towards examining this hypothesis.
13.3. Co-ordination of nucleases
Interstrand crosslink repair involves number of coordinated
nucleolytic events. There is a plethora of nucleases implicated as
being important in the repair of crosslink lesions. To advance our
understanding of how these events are regulated requires dissec-
tion of the step-wise order of events that guides repair through
unhooking events, translesion synthesis and recombination events.
Since there is likely to be redundancy between the functions of
these nuclease complexes, dissecting these events in vivo may
not allow us to gain an accurate picture of how the nucleolytic re-
pair events are regulated. In this instance in vitro recapitulation of
these reactions may be the only way to know the absolute require-
ments for, and order of, events at an interstrand crosslink lesion.
Implicit in gaining an understanding of nuclease regulation is the
identiﬁcation of how nucleases are organized at sites of repair.
The identiﬁcation of FANCP/SLX4 shed some light on the recruit-
ment of nucleases to the sites of damage. The docking sites for
these recruitment factors will provide important insight into
dynamics of these processes and understanding of the ubiquitin
binding motifs in these proteins will be essential.
13.4. Ubiquitin-like modiﬁcations
Ubiquitin modiﬁcation modulates molecular interactions and
localization of substrates. Other small molecule modiﬁcations have
been identiﬁed that like ubiquitin are conjugated onto target sub-
strates and can play a role in the regulation of cellular processes
such as cellular signal transduction, cell cycle regulation and
DNA repair. SUMO (small ubiquitin-like modiﬁer) modiﬁcation
dynamics are similar to that of ubiquitylation in that they involve
an enzymatic cascade to conjugate SUMO to target substrates. This
equilibrium is maintained by desumoylating enzymes. In yeast
PCNA is a platform for both ubiquitination and SUMOylation
[106]. SUMOylation of PCNA takes place during S-phase creating
a binding site for down-stream effectors and can suppress homol-
ogous recombination. SUMOylation motifs are well characterised
and various protein components of the FA pathway harbor putative
SUMOylation sites. It will be interesting to see if and how
SUMOylation and indeed other ubiquitin-like modiﬁcations may
be involved in FA pathway function.
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